Incorruptible Evidence: Blockchain's Promise for Faster Drug Approvals w. Dominik Lysek

Send us Fan MailDominik Lysek, CEO of PharmaTrail, explains how blockchain technology can solve trust issues in clinical trials by providing an incorruptible audit trail that verifies data integrity. This solution could significantly accelerate the time required for regulatory approvals, partnerships, and acquisitions, ultimately getting treatments to patients faster.• Blockchain provides a complete, unchangeable audit trail where data can only be added, never deleted• Most clinical data (99.9%) has integrity, but proving this to outsiders is time-consuming and costly• PharmaTrail uses private blockchain technology alongside traditional databases for optimal security and functionality• Blockchain verification can maintain momentum through due diligence processes, preventing deals from stalling• The technology creates trust by enabling independent verification of data integrity• Current systems face challenges with data credibility that delay patient access to treatments• Private blockchains protect patient data while still providing the benefits of immutable record-keepingVisit Labtolives.com Do you want to try the quiz from this episode? Find the link on our LinkedIn profile: https://www.linkedin.com/company/labtolives/ Would you like to join the show as a guest or collaborator? Find out how on our website: https://www.labtolives.com/ Support the show________Reach out to Ivanna RosendalJoin the conversation on our LinkedIn pageVisit www.labtolives.com HostsAlexander Booth aka the MedTech GuyDimitri Borisevich aka the start-up GuyIvanna Rosendal aka the R&D pharma Gal